Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Germ cell tumors: dose-intensive therapy

W Siegert1, J Beyer

  • 1Abt. für Innere Medizin und Poliklinik m.S. Hämatologie und Onkologie Virchow Klinikum, Humboldt Universität, Berlin, Germany.

Seminars in Oncology
|April 30, 1998
PubMed
Summary

High-dose chemotherapy using carboplatin and etoposide offers a safe and effective treatment for germ cell tumors, even in relapsed or advanced cases. This intensive approach shows promise for overcoming cisplatin resistance and improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.

Clinical science (London, England : 1979)·2000
Same author

Reconstruction and visualization of irregularly sampled three- and four-dimensional ultrasound data for cerebrovascular applications.

Ultrasound in medicine & biology·2000
Same author

[Comparison of hypoglycemia perception and hormonal counterregulation in controlled hypoglycemia. A contribution to diagnosis of hypoglycemia unawareness syndrome in type 1 diabetic patients].

Deutsche medizinische Wochenschrift (1946)·2000
Same author

[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].

Deutsche medizinische Wochenschrift (1946)·2000
Same author

[Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation].

Deutsche medizinische Wochenschrift (1946)·2000
Same author

Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence.

Journal of virology·2000

Area of Science:

  • Oncology
  • Hematology
  • Pharmacology

Background:

  • Germ cell tumors (GCTs) can be challenging to treat, especially in relapsed or advanced stages.
  • Conventional chemotherapy may not be sufficient for all GCT patients.
  • Advances in supportive care, including growth factors and autologous stem cell transplantation, have improved the safety of intensive chemotherapy.

Purpose of the Study:

  • To evaluate the efficacy and safety of dose-intensive chemotherapy with carboplatin and etoposide in germ cell tumor patients.
  • To explore the potential of high-dose chemotherapy to overcome cisplatin resistance.
  • To assess the feasibility of initiating high-dose treatment earlier in the disease course.

Main Methods:

  • Administration of carboplatin (1000-2000 mg/m2) and etoposide (1200-2400 mg/m2) in one or two cycles.

Related Experiment Videos

  • Use of growth factors and autologous stem cells for hematopoietic rescue.
  • Treatment applied to patients with multiply relapsed or advanced GCTs, and considered for first-line salvage or poor-risk patients.

    • Main Results:

    • Achieved long-term disease-free survival in a subset of patients with previously incurable disease.
    • Demonstrated that high-dose carboplatin and etoposide can overcome cisplatin refractoriness.
    • High-dose treatment (HDT) is better tolerated when instituted earlier in the disease course.

    Conclusions:

    • Dose-intensive chemotherapy with carboplatin and etoposide is a viable and relatively safe option for GCT patients, including those with refractory disease.
    • Early application of HDT may lead to superior tumor eradication and improved outcomes.
    • Further randomized studies are needed to confirm the definitive value of HDT in GCT treatment.